دورية أكاديمية

Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study

التفاصيل البيبلوغرافية
العنوان: Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
المؤلفون: Aggarwal, Neil R., Beaty, Laurel E., Bennett, Tellen D., Fish, Lindsey E., Jacobs, Jason R., Mayer, David A., Molina, Kyle C., Peers, Jennifer L., Richardson, Douglas B., Russell, Seth, Varela, Alejandro, Webb, Brandon J., Wynia, Matthew K., Xiao, Mengli, Carlson, Nichole E., Ginde, Adit A.
المصدر: In The Lancet Regional Health - Americas March 2024 31
قاعدة البيانات: ScienceDirect
الوصف
تدمد:2667193X
DOI:10.1016/j.lana.2024.100693